Congenital myasthenic syndromes: Progress over the past decade

Muscle and Nerve

Volumn 27, Issue 1, 2003, Pages 4-25

  Engel, Andrew G ^a   Ohno, Kinji ^a   Sine, Steven M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acetylcholine receptor; Acetylcholinesterase; Choline acetyltransferase; Congenital myasthenic syndromes; Neuromuscular junction; Patch clamp recordings; Rapsyn

Indexed keywords

3,4 DIAMINOPYRIDINE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; COLLAGEN; EPHEDRINE; FLUOXETINE; NEOSTIGMINE METHYL SULFATE; NERVE PROTEIN; PYRIDOSTIGMINE; QUINIDINE; QUINIDINE SULFATE; RAPSYN; RECEPTOR SUBUNIT;

ACETYLCHOLINE RELEASE; BASEMENT MEMBRANE; BIOSYNTHESIS; CATALYSIS; CLINICAL FEATURE; CONGENITAL MYASTHENIC SYNDROME; DISEASE CLASSIFICATION; ENZYME SUBUNIT; GENE EXPRESSION; GENE MUTATION; HUMAN; KINETICS; NEUROMUSCULAR JUNCTION DISORDER; PATCH CLAMP; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT;

HUMANS; MYASTHENIC SYNDROMES, CONGENITAL; RECEPTORS, CHOLINERGIC;

EID: 0037233692     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10269     Document Type: Article

References (148)

1. Abicht A, Stucka R, Karcagi V, Hercegfalvi A, Horváth R, Mortier W, Schara U, Ramaekers V, Jost W, Brunner J, Janssen G, Seidel U, Schlotter B, Pongratz D, Rüdel R, Lochmüller H. A common mutation (ε1267delG) in congenital myasthenic patients of Gipsy ethnic origin. Neurology 1999;53:1564-1569.
2. Abicht A, Stucka R, Song I-H, Karcagi V, Kugler K, Baumgarten-Walczak A, Stier c, Pongratz D, Mortier W, Müller-Ferber W, Lochmüller H. Genetic analysis of the entire AChR ε-subunit gene in 52 congenital myasthenic families. Acta Myol 2000;19:23-27.
3. Adams ME, Kramarcy M, Krall SP, Rossi SG, Rotundo RL, Sealock R, Froehner SC. Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J Cell Biol 2000;150:1385-1398.
4. Akabas MH, Kaufmann C, Archdeacon P, Karlin A. Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit. Neuron 1994;13:919-927.
5. Altiok N, Altiok K, Changeux J-P. Heregulin-stimulated acetylcholine receptor gene expression in muscle - requirement for MAP kinase and evidence for parallel inhibitory pathway independent electrical activity. EMBO J 1997;16:717-725.
6. Apel ED, Glass DJ, Moscosco LM, Yancopoulos GD, Sanes JR. Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron 1997;18:623-625.
7. Apel ED, Roberds SL, Campbell KP, Merlie JP. Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex. Neuron 1995;15:115-126.
8. Apparsundaram S, Ferguson SM, George ALJr, Blakely RD. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem Biophys Res Commun 2000;276:862-867.
9. Auerbach A, Lingle CJ. Heterogeneous kinetic properties of acetylcholine receptor channels in Xenopus oocytes. J Physiol (Lond) 1986;378:119-140.
10. Bady B, Chauplannaz G, Carrier H. Congenital Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1987;50:476-478.
11. Banwell BL, Russel J, Fukudome T, Shen X-M, Stilling G, Engel AG. Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency. J Neuropathol Exp Neurol 1999;58:832-846.
12. Bartoli M, Cohen JB. Identification of the modular domains of rapsyn binding to nicotinic acetylcholine receptor (AChR) and to dystroglycan. Soc Neurosci Abstract 2001;27: Program No. 904.16.
13. Bartoli M, Ramarao MK, Cohen JB. Interactions of the rapsyn RING-H2 domain with dystroglycan. J Biol Chem 2001;276:24911-24917.
14. Bon S, Coussen F, Massoulié J. Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail. J Biol Chem 1997;272:3016-3021.
15. Bööj S, Larsson P-A, Dahllöf A-G, Dahlström A. Axonal transport of synapsin I and cholinergic synaptic vesicle-like material. Further immunohistochemical evidence for transport of axonal cholinergic transmitter vesicles in motor neurons. Acta Physiol Scand 1986;128:155-165.
16. Bouzat C, Bren N, Sine SM. Structural basis of different gating kinetics of fetal and adult acetylcholine receptors. Neuron 1994;13:1395-1402.
17. Brejc K, van Dijk WV, Schuurmans M, van der Oost J, Smit AB, Sixma TK. Crystal structure of ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001;411:269-276.
18. Brengman JM, Ohno K, Milone M, Friedman RL, Feldman RG, Engel AG. Identification and functional characterization of eight novel acetylcholine receptor mutations in six congenital myasthenic syndrome kinships. Neurology 2000;54(Suppl 3):A182-A183.
19. Brengman JM, Ohno K, Shen X-M, Engel AG. Congenital myasthenic syndrome due to two novel mutations in the acetylcholine receptor E subunit gene. Muscle Nerve 1998;21 (Suppl 7): S120.
20. Brownlow S, Webster R, Croxen R, Brydson M, Neville B, Lin J-P, Vincent A, Newsom-Davis J, Beeson D. Acetylcholine receptor δ subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest 2001;108:125-130.
21. Byring RF, Pihko H, Shen X-M, Gustafsson B, Hackman P, Ohno K, Engel AG, Udd B. Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscul Disord 2002;12:548-553.
22. Cartaud A, Coutant S, Petrucci TC, Cartaud J. Evidence for in situ and in vitro association between β-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse. J Biol Chem 1998;273:11321-11326.
23. 3H] nicotine photoincorporation in the gamma subunit of Torpedo nicotinic acetylcholine receptor. FEBS Lett 1998;423:223-226.
24. Colquhoun D, Sakmann B. Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels. Nature 1981;294:464.
25. Conomy JP, Levisohn M, Fanaroff A. Familial infantile myasthenia gravis: a cause of sudden death in young children. J Pediatr 1975;87:428-429.
26. Corringer JP, Bertrand S, Galzi J-L, Devillers-Thiéry A, Changeux J-P, Bertrand D. Mutational analysis of the charge selectivity filter of the α7 nicotinic acethylcholine receptor. Neuron 1999;22:831-843.
27. Corringer JP, Le Novère N, Changeux J-P. Nicotine receptors at the amino acid level. Annu Rev Pharmacol Toxicol 2000;40:431-458.
28. Croxen R, Newland C, Beeson D, Oosterhuis H, Chauplanaz G, Vincent A, Newsom-Davis J. Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1997;6:767-774.
29. Croxen R, Newland C, Betty M, Vincent A, Newsom-Davis J, Beeson D. Novel functional ε-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome. Ann Neurol 1999;46:639-647.
30. Croxen R, Newsom-Davis J, Beeson D. Endplate acetylcholine receptor deficiency syndrome: two new mutations. Acta Myol 2000;19:45-48.
31. Croxen R, Young C, Slater C, Haslam S, Brydson M, Vincent A, Beeson D. Endplate γ- and ε-subunit mRNA levels in AChR deficiency syndrome due to ε subunit null mutations. Brain 2001;124:1362-1372.
32. Czajkowski C, Karlin A. Structure of the nicotinic receptor acetylcholine binding site. J Biol Chem 1995;270:3160-3164.
33. Dennis M, Giraudat J, Kotzyba-Hilbert F, Goeldner M, Hirth C, Chang J, Lazure C, Cretien M, Changeux J-P. Amino acids of Torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry 1988;27:2346-2357.
34. Deprez PN, Inestrosa NC. Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase. J Biol Chem 1995;270:11043-11046.
35. Dettbarn WD. Pesticide induced muscle necrosis: mechanism and prevention. Fund Appl Toxicol 1984;4:S18-S26.
36. Deymeer F, Serdaroglu P, Gülsen-Parman Y, Öztürk A, Özdemir C. Clinical characteristics of a group of Turkish patients having a benign CMS phenotype with ptosis and marked ophthalmoparesis and mutations in the acetylcholine receptor epsilon subunit gene. Acta Myol 2000;19:29-32.
37. Deymeer F, Serdaroglu P, Ozdemir C. Familial infantile myasthenia: confusion in terminology. Neuromuscul Disord 1999;9:129-130.
38. Donger C, Krejci E, Serradell P, Eymard B, Bon S, Nicole S, Chateau D, Gary F, Fardeau M, Massoulié J, Guicheney P. Mutation in the human acetylcholinesterase-associated gene, COLQ is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency. Am J Hum Genet 1998;63:967-975.
39. Eiden LE. The cholinergic gene locus. J Neurochem 1998;70:2227-2240.
40. Engel AG, Lambert EH. Congenital myasthenic syndromes. Electroencephalogr Clin Neurophysiol Suppl 1987;39:91-102.
41. Engel AG, Lambert EH, Gomez MR. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1977;1:315-330.
42. Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 1982;11:553-569.
43. Engel AG, Ohno K, Bouzat C, Sine SM, Griggs RG. End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit. Ann Neurol 1996;40:810-817.
44. Engel AG, Ohno K, Milone M, Wang H-L, Nakano S, Bouzat C, Pruitt JN, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227.
45. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes. In: Engel AG, editor. Myasthenia gravis and myasthenic disorders. New York: Oxford University Press; 1999. p 251-297.
46. Erickson JD, Varoqui H, Eiden LE, Schafer MK, Modi W, Diebler M, Weihe E, Rand J, Bonnet TI, Usdin TB. Functional identification of a vesicular acetylcholine transporter and its expression from a 'cholinergic' gene locus. J Biol Chem 1994;269:21929-21932.
47. Finer-Moore J, Stroud RM. Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc Natl Acad Sci USA 1984;81:155-159.
48. Frauenfelder H, Lesson DT. The energy landscape of nonbiological and biological molecules. Nat Struct Biol 1998;5:757-759.
49. Froehner SC, Luetje CW, Scotland PB, Patrick J. The postsynaptic 43K protein clusters muscle nicotinic acetylcholine receptors in Xenopus oocytes. Neuron 1990;5:403-410.
50. Fukudome T, Ohno K, Brengman JM, Engel AG. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport 1998;9:1907-1911.
51. Galzi J-L, Revah F, Black D, Goeldner M, Hirth C, Changeux J-P. Identification of a novel amino acid α-tyrosine 93 within the cholinergic ligand-binding sites of the acetylcholine receptor by photoaffinity labeling. J Biol Chem 1990;265:10430-10437.
52. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie MP, Sanes JR. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 1996;85:525-535.
53. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR, Merlie JP. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 1995;377:232-236.
54. Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah H, Mattson K, Burden SJ, Distefano PS, Valenzuela DM, Dechiara TM, Yancopoulos GD. Agrin acts via MuSK receptor complex. Cell 1996;85:513-523.
55. Gomez CM, Maselli R, Gammack J, Lasalde J, Tamamizu S, Cornblath DR, Lehar M, McNamee M, Kuncl R. A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann Neurol 1996;39:712-723.
56. Gomez CM, Maselli R, Staub J, Day JW, Cens T, Wollman RL, Charnet PC. Novel δ and β subunit acetylcholine receptor mutations in the slow-channel syndrome demonstrate phenotypic variability. Soc Neurosci Abstr 1998;24:484.
57. Gomez CM, Maselli R, Vohra BPS, Navedo M, Stiles JR, Charnet P, Schott K, Rojas L, Keesey J, Verity A, Wollman RW, Lasalde-Dominici J. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanism. Ann Neurol 2002;51:102-112.
58. Grady RM, Merlie JP, Sanes JR. Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 1997;136:871-882.
59. Greer M, Schotland M. Myasthenia gravis in the newborn. Pediatrics 1960;26:101-108.
60. Grosman C, Salamone FN, Sine SM, Auerbach A. The extracellular linker of muscle acetylcholine receptor channels is a gating control element. J Gen Physiol 2000;116:327-339.
61. Harper CM. Electrodiagnosis of endplate disease. In: Engel AG, editor. Myasthenia gravis and myasthenic disorders. New York: Oxford University Press; 2002. p 65-84.
62. Harper CM, Engel AG. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol 1998;43:480-484.
63. Harper CM, Engel AG. Treatment of 31 congenital myasthenic syndrome patients with 3, 4-diaminopyridine. Neurology 2000;54(Suppl 3):A395.
64. Harper CM, Engel AG, Fukudome T, Zochodne DW, Friedli WG. Treatment of slow channel congenital myasthenic syndrome (SCCMS) with fluoxetine. Neurology 2002;58(Suppl 3):A329.
65. Hart Z, Sahashi K, Lambert EH, Engel AG, Lindstrom J. A congenital, familial, myasthenic syndrome caused by a presynaptic defect of transmitter resynthesis of mobilization. Neurology 1979;29:559.
66. Hercegfalvi A, Abicht A, Karcagi V, Lochmüller H. Case report: congenital myasthenic syndrome in a Gipsy family showing pseudodominant pattern of inheritance. Acta Myol 2000;19:49-51.
67. Hutchinson DO, Walls TJ, Nakano S, Camp S, Taylor P, Harper CM, Groover RV, Peterson HA, Jamieson DG, Engel AG. Congenital endplate acetylcholinesterase deficiency. Brain 1993;116:633-653.
68. Ishigaki K, Nicolle D, Krejci E, Osawa M, Guicheney P, Koenig J, Fardeau M, Eymard B, Hantai D. Two novel mutations in the ColQ gene causing endplate acetylcholinesterase deficiency. Neuromuscul Disord 2001;11:666-667.
69. Jackson MB. Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor. Proc Natl Acad Sci USA 1989;86:2199-2203.
70. Karlin A, Akabas MH. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 1994;15:1231-1244.
71. Katz B, Miledi R. The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol (Lond) 1973;231:549-574.
72. Katz B, Thesleff S. A study of the 'desensitization' produced by acetylcholine at the motor end-plate. J Physiol (Lond) 1957;138:63-80.
73. Kiene L-M, Stadler H. Synaptic vesicles in electromotoneurons. I. Axonal transport, site of transmitter uptake and processing of a core proteoglycan during maturation. EMBO J 1987;6:2209-2215.
74. Kimbell LM, Ohno K, Rotundo RL, Engel AG. Transplanting mutant human collagenic tailed acetylcholinesterase onto the frog neuromuscular junction: evidence for an attachment defect in a congenital myasthenic syndrome. Mol Biol Cell 2001;12:(Suppl) 161a.
75. Labarca C, Nowak MW, Zhang H, Tang L, Deshpande P, Lester HA. Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 1995;376:514-516.
76. Lambert EH, Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann NY Acad Sci 1971;183:183-199.
77. Le Novère N, Corringer PJ, Changeux J-P. Improved secondary structure predictions for a nicotinic receptor subunit: incorporation of solvent accessibility and experimental data into a two-dimensional representation. Biophys J 1999;76:2329-2345.
78. Llinás R, Sugimori M, Lin J-W, Leopold P-L, Brady ST. ATP-dependent directional movement of rat synaptic vesicles injected into the presynaptic terminal of squid giant synapse. Proc Natl Acad Sci USA 1989;86:5656-5660.
79. Lundh H, Nilsson O, Rosen I. Treatment of Lambert-Eaton syndrome: 3, 4-diaminopyridine and pyridostigmine. Neurology 1984;34:1324-1330.
80. Maimone MM, Merlie JP. Interaction of the 43 kd postsynaptic protein with all subunits of the muscle nicotinic acetylcholine receptor. Neuron 1993;11:53-66.
81. Maimone MM, Merlie JP. The intracellular domain of the nicotinic acetylcholine receptor α subunit mediates its coclustering with rapsyn. Mol Cell Neurosci 1999;14:340-354.
82. Maselli R, Chen M, Chen T-Y, Kong D, Constance B, McDonald C, Fairclough RH, Gomez CM, Wollman RL. A heteroallelic nonsense/missense mutation in the acetylcholine receptor α-subunit causing severe endplate AChR deficiency. Neurology 2002;58(Suppl 3):A230.
83. Maselli R, Chen M, Chen T-Y, Kong DZ, Agius MA, Bowe C, Wollman RL, Gomez CM. Severe low-affinity fast-channel syndrome due to a heteroallelic nonsense/missense mutation in the acetylcholine receptor ε-subunit. Neurology 2002;58(Suppl 3):A228.
84. Maselli RA, Kong DZ, Bowe CM, McDonald CM, Ellis WG, Agius MA, Gomez CM, Richman DP, Wollman RL. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology 2001;57:279-289.
85. Maselli RA, Soliven BC. Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and d-tubocurarine. Muscle Nerve 1991;14:1182-1188.
86. McQuillen MP. Familial limb-girdle myasthenia. Brain 1966;89:121-132.
87. Middleton L, Ohno K, Christodoulou K, Brengman JM, Milone M, Neocleous V, Serdaroglu P, Deymeer F, Özdemir C, Mubaidin A, Horany K, Al-Shebab A, Mavromatis I, Mylonas I, Tsingis M, Zamba E, Pantzaris M, Kyriallis K, Engel AG. Congenital myasthenic syndromes linked to chromosome 17p are caused by defects in acetylcholine receptor ε subunit gene. Neurology 1999;53:1076-1082.
88. Milone M, Ohno K, Pruitt JN, Brengman JM, Sine SM, Engel AG. Congenital myasthenic syndrome due to frameshifting acetylcholine receptor epsilon subunit mutation. Soc Neurosci Abstr 1996;22:1942-1942.
89. Milone M, Shen X-M, Ohno K, Harper CM, Fukudome K, Stilling G, Brengman JM, Engel AG. Unusual congenital myasthenic syndrome with endplate AChR deficiency caused by alpha subunit mutations and a remitting-relapsing course. Neurology 1999;52(Suppl 2):185-186.
90. Milone M, Wang H-L, Ohno K, Fukudome T, Pruitt JN, Bren N, Sine SM, Engel AG. Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 1997;17:5651-5665.
91. Milone M, Wang H-L, Ohno K, Prince RJ, Shen X-M, Brengman JM, Griggs RC, Engel AG. Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor ε subunit. Neuron 1998;20:575-588.
92. Mishina M, Tobimatsu T, Imoto K, Tanaka K, Futjita Y, Fukuda K, Kurasaki M, Takahashi H, Morimoto Y, Hirose T. Location of functional regions of acetylcholine receptor alpha-subunit by site directed mutagenesis. Nature 1985;313:364-369.
93. Mittaud P, Marangi A, Erb-Vörgtli S, Fuhrer C. Agrin induced activation of acetylcholine receptor-bound Src family kinases requires rapsyn an correlates with acetylcholine receptor clustering. J Biol Chem 2001;276:14505-14513.
94. Miyazawa A, Fujiyoshy Y, Unwin N. Nicotinic acetylcholine receptor at 4.6A resolution: transverse tunnels in the channel wall. J Mol Biol 1999;288:765-786.
95. Monod J, Wyman J, Changeux J-P. On the nature of allosteric transitions: a plausible model. J Mol Biol 1965;12:88-118.
96. Mora M, Lambert EH, Engel AG. Synaptic vesicle abnormallity in familial infantile myasthenia. Neurology 1987;37:206-214.
97. Naranjo D, Brehm P. Modal shifts in acetylcholine receptor channel gating confer subunit-dependent desensitization. Science 1993;260:1811-1814.
98. Newey SA, Gramolini AO, Wu J, Izfeind G, Smin BJ, Vies KE, Ake DJ. A novel mechanism for modulating synaptic gene expression: differential localization of α-dystrobrevin transcripts in skeletal muscle. Mol Cell Neurosci 2001;17:127-140.
99. Nichols P, Croxen R, Vincent A, Rutter R, Hutchinson M, Newsom-Davis J, Beeson D. Mutation of the acetylcholine receptor ε-subunit promoter in congenital myasthenic syndrome. Ann Neurol 1999;45:439-443.
100. Oda Y, Nakanishi I, Deguchi T. A complementary, DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells. Brain Res Mol Brain Res 1992;16:287-294.
101. Ohno K, Anlar B, Engel AG. Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acewlcholine receptor ε subunit gene. Neuromuscul Disord 1999;9:131-135.
102. Ohno K, Anlar B, Özdirim E, Brengman JM, De Bleecker J, Engel AG. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor. Ann Neurol 1998;44:234-241.
103. Ohno K, Brengman JM, Felice KJ, Cornblath DR, Engel AG. Congenital endplate acetylcholinesterase deficiency caused by a nonsense mutation and an A-to-G splice site mutation at position 3 of the collagen-like tail subunit gene (COLQ): How does G at position 3 result in aberrant splicing? Am J Hum Genet 1999;65:635-644.
104. Ohno K, Brengman JM, Tsujino A, Engel AG. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asunmetric enzyme. Proc Natl Acad Sci USA 1998;95:9654-9659.
105. Ohno K, Engel AG, Brengman JM, Harper CM, Shen X-M, Heidenreich FR, Vincent A, Milone M, Tan E, Demirci M, Walsh P, Nakano S, Akiguchi I. The spectrum of mutations causing endplate acetylcholinesterase deficiency. Ann Neurol 2000;47:162-170.
106. Ohno K, Engel AG, Milone M, Brengman JM, Sieb JP, Iannaccone S. A congenital myasthenic syndrome with severe acetylcholine receptor deficiency caused by heteroallelic frameshifting mutations in the epsilon subunit. Neurology 1995;45 (Suppl 4):A283.
107. Ohno K, Engel AG, Shen X-M, Selcen D, Brengman JM, Harper CM, Tsujino A, Milone M. Rapsyn mutations in humans cause endplate acetylcholine receptor deficiency and myasthenic syndrome. Am J Hum Genet 2002;70:875-885.
108. Ohno K, Fukudome T, Nakano S, Milone M, Feasby TE, Tyce GM, Engel AG. Mutational analysis in a congenital myasthenic syndrome reveals a novel acetylcholine receptor epsilon subunit mutation. Soc Neurosci Abstr 1996;22:234-234.
109. Ohno K, Hutchinson DO, Milone M, Brengman JM, Bouzat C, Sine SM, Engel AG. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proc Natl Acad Sci USA 1995;92:758-762.
110. Ohno K, Milone M, Brengman JM, Lo Monaco M, Evoli A, Tonali P, Engel AG. Slow-channel congenital myasthenic syndrome caused by a novel mutation in the acetylcholine receptor ε subunit. Neurology 1998;50:A432.
111. Ohno K, Quiram P, Milone M, Wang H-L, Harper CM, Pruitt JN, Brengman JM, Pao L, Fischbeck KH, Crawford TO, Sine SM, Engel AG. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet 1997;6:753-766.
112. Ohno K, Shen X-M, Fukudome T, Tsujino A, Brengman JM, De Vivo DC, Engel AG. First report of acetylcholine receptor δ subunit mutation causing endplate AChR deficiency. Neurology 2001;56(Suppl 3):232-233.
113. Ohno K, Tsujino A, Anlar B, Engel AG. A 16-bp duplication of splice-acceptor site results in silencing of the downstream copy of the splice acceptor site. How are duplicated splice-acceptor sites selected in pre-mRNA splicing? Am J Hum Genet 2001;69(Suppl.):368.
114. Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, Beyring R, Robb S, Kirkham FJ, Engel AG. Choline acelyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 2001;98:2017-2022.
115. Ohno K, Wang H-L, Milone M, Bren N, Brengman JM, Nakano S, Quiram P, Pruitt JN, Sine SM, Engel AG. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron 1996;17:157-170.
116. Ohno K, Wang H-L, Shen X-M, Milone M, Bernasconi L, Sine SM, Engel AG. Slow-channel mutations in the center of the M1 transmembrane domain of the acetylcholine receptor α subunit. Neurology 2000;54(Suppl 3):A183.
117. Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N. The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell 1995;81:769-780.
118. Okuda T, Haga T, Kanai Y, Endou H, Ishihara T, Katsura I. Identification and characterization of the high-affinity choline transporter. Nat Neurosci 2000;3:120-125.
119. Phillips WD, Kopta C, Blount P, Gardner PD, Steinbach JH, Merlie JP. ACh-rich receptor membrane domains organized in fibroblasts by recombinant 43-kilodalton protein. Science 1991;251:568-570.
120. Prince RJ, Sine SM. The ligand binding domains of the nicotinic acetylcholine receptor. In: Barrantes FJ, editor. The nicotinic acetylcholine receptor: current views and future trends. Austin: Landes Bioscience; 1998. p 31-59.
121. Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995;64:403-434.
122. Quiram P, Ohno K, Milone M, Patterson MC, Pruitt NJ, Brengman JM, Sine SM, Engel AG. Mutation causing congenital myasthenia reveals acetylcholine receptor β/δ subunit interaction essential for assembly. J Clin Invest 1999;104:1403-1410.
123. Ramarao MK, Bianchetta MJ, Lanken J, Cohen JB. Role of rapsyn tetratrichopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering. J Biol Chem 2001;276:7475-7483.
124. Ramarao MK, Cohen JB. Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc Natl Acad Sci USA 1998;95:4007-4012.
125. Reimer RJ, Fon AE, Edwards RH. Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Curr Opin Neurobiol 1998;8:405-412.
126. Robertson WC, Chun RWM, Kornguth SE. Familial infantile myasthenia. Arch Neurol 1980;37:117-119.
127. Sadeh M. Benign congenital myasthenic syndrome with facial malformations. Acta Myol 2000;19:33-36.
128. Salpeter MM, Kasprzak H, Feng H, Fertuck H. End-plates after esterase inactivation in vivo: correlation between esterase concentration, functional response and fine structure. J Neurocytol 1979;8:95-115.
129. Sandrock AW, Dryer SE, Rosen KM, Gozani SM, Kramer R, Theill LE, Fischbach GD. Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science 1997;276:599-603.
130. Shapira YA, Sadeh ME, Bergtraum MP, Tsujino A, Ohno K, Shen X-M, Brengman JM, Edwardson S, Matoh I, Engel AG. The novel COLQ mutations and variation of phenotypic expressivity due to G240X. Neurology 2002;58:603-609.
131. Shen X-M, Ohno K, Fukudome T, Brengman JM, Engel AG. Deletion of a single codon from the long cytoplasmic loop of the nAChR subunit gene causes brief single channel currents. Soc Neurosci Abstr 1999;25:1721.
132. Shen X-M, Ohno K, Milone M, Brengman JM, Spilsbury PR, Engel AG. Fast-channel syndrome. Neurology 2001;56(Suppl. 3):A60.
133. Shen X-M, Tsujino A, Ohno K, Brengman JM, Gingold M, Engel AG. A novel fast-channel congenital myasthenic syndrome caused by a mutation in the Cys-loop domain of the acetylcholine receptor ε subunit. Neurology 2000;54(Suppl 3):A138.
134. Si J, Luo Z, Mei L. Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase. J Biol Chem 1996;271:19752-19759.
135. Sieb JP, Kraner S, Rauch M, Steinlein OK. Immature endplates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations. Hum Genet 2000;107:160-464.
136. Sieb JP, Kraner S, Schrank B, Reitter B, Goebel TH, Tzartos SJ, Steinlein OK. Severe congenital myasthenic syndrome due to homozygosity of the 1293insG epsilon-acetylcholine receptor subunit mutation. Ann Neurol 2000;48:379-383.
137. Sieb JP, Milone M, Engel AG. Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Res 1996;712:179-189.
138. Sine SM, Claudio T, Sigworth FJ. Activation of Torpedo acetylcholine receptors expressed in mouse fibroblasts: single-channel current kinetics reveal distinct agonist binding affinities. J Gen Physiol 1990;96:395-437.
139. Sine SM, Ohno K, Bouzat C, Auerbach A, Milone M, Pruitt JN, Engel AG. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 1995;15:229-239.
140. Südhof TC, Jahn R. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron 1991;6:665-677.
141. Tseng CN, Yao Y, Wang JM, Viroonchatapan N, Rothe E, Wang ZZ. A synaptic isoform of NRAP interacts with the postsynaptic 43K protein rapsyn and links it to the cytoskeleton at the neuromuscular junction. Soc Neurosci Abstr 2001;27:Program No. 694.6.
142. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 1995;373:37-43.
143. Walls TJ, Engel AG, Nagel AS, Harper CM, Trastek VF. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann NY Acad Sci 1993;681:461-468.
144. Wang D, Chirar DC, Xie Y, Cohen JB. Probing the structure of the nicotinic acetylcholine receptor with 4-benzoylbenzoyl choline, a novel photoaffinity competitive antagonist. J Biol Chem 2000;275:28666-28674.
145. Wang H-L, Auerbach A, Bren N, Ohno K, Engel AG, Sine SM. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol 1997;109:757-766.
146. Wang H-L, Milone M, Ohno K, Shen X-M, Tsujino A, Batocchi AP, Tonali P, Brengman JM, Engel AG, Sine SM. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci 1999;2:226-233.
147. Wang H-L, Ohno K, Milone M, Brengman JM, Evoli A, Batocchi AP, Middleton L, Christodoulou K, Engel AG, Sine SM. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol 2000;116:449-460.
148. Zhang Y, Chen J, Auerbach A. Activation of recombinant mouse acetylcholine receptors by acetylcholine, carbamylcholine and tetraethylammonium. J Physiol (Lond) 1995;486:189-206.